Skip to main navigation Skip to search Skip to main content

Intravenous ferric derisomaltose in patients with heart failure and iron deficiency in the UK (IRONMAN): an investigator-initiated, prospective, randomised, open-label, blinded-endpoint trial

  • Paul R. Kalra
  • , John G.F. Cleland
  • , Mark C. Petrie
  • , Elizabeth A. Thomson
  • , Philip A. Kalra
  • , Iain B. Squire
  • , Fozia Z. Ahmed
  • , Abdallah Al-Mohammad
  • , Peter J. Cowburn
  • , Paul W.X. Foley
  • , Fraser J. Graham
  • , Alan G. Japp
  • , Rebecca E. Lane
  • , Ninian N. Lang
  • , Andrew J. Ludman
  • , Iain C. Macdougall
  • , Pierpaolo Pellicori
  • , Robin Ray
  • , Michele Robertson
  • , Alison Seed
    • Ian Ford (Lead / Corresponding author), IRONMAN Study Group

Research output: Contribution to journal › Article › peer-review

333   Link opens in a new tab Citations (Scopus)
164 Downloads (Pure)

Fingerprint

Dive into the research topics of 'Intravenous ferric derisomaltose in patients with heart failure and iron deficiency in the UK (IRONMAN): an investigator-initiated, prospective, randomised, open-label, blinded-endpoint trial'. Together they form a unique fingerprint.
Sort by

Keyphrases

Medicine and Dentistry

Pharmacology, Toxicology and Pharmaceutical Science